TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -6 | -7 | 60 | 30 | -5 | -23 | 8 |
| S | %wins | 100 | 100 | 0 | 0 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/09 16:42 | 7/2/09 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lambert John A | MD | D | S | -98 | 2.82 | 17 | -35 | -30 | 80 | D | -6 | 27 | 52 | 256 | 59 | -1 | 20 | 15 | -6 | -7 | 60 | 30 | -5 | -23 | |
8/22/03 12:41 | 8/21/03 | CHIR | Chiron Corp | DE | Health | Drug | Pharmaceutical Preparations | Lambert John A | CA | O | VP,P,Chi | S | -2,487 | 49.75 | 0 | -50 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |